T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
SiTime
SITM
$20.7B
| $10.8M | ﹤0.01% |
66,358
-2,127
| -3% | -$402K |
|
1302
Ormat Technologies
ORA
$6.98B
| $10.8M | ﹤0.01% |
137,809
+75,633
| +122% | +$5.96M |
|
|
NBP
1303
NovaBridge Biosciences American Depositary Shares
NBP
$220M
| $10.8M | ﹤0.01% |
952,801
-4,442,356
| -82% | -$53.3M |
|
1304
American Airlines Group
AAL
$9.97B
| $10.6M | ﹤0.01% |
832,562
-85,435
| -9% | -$1.42M |
|
1305
Teladoc Health
TDOC
$1.26B
| $10.5M | ﹤0.01% |
317,131
-62,950
| -17% | -$2.67M |
|
1306
ProPetro Holding
PUMP
$1.42B
| $10.5M | ﹤0.01% |
1,046,492
+368,582
| +54% | +$4.85M |
|
1307
Tapestry
TPR
$25.9B
| $10.3M | ﹤0.01% |
338,766
-53,347
| -14% | -$1.75M |
|
1308
Nabors Industries
NBR
$1.35B
| $10.1M | ﹤0.01% |
75,626
+70,430
| +1,355% | +$11M |
|
1309
Royal Caribbean
RCL
$82.9B
| $10.1M | ﹤0.01% |
288,622
-27,226
| -9% | -$1.69M |
|
|
GTM
1310
ZoomInfo Technologies
GTM
$1.25B
| $10M | ﹤0.01% |
300,950
+60,932
| +25% | +$2.69M |
|
1311
Ginkgo Bioworks
DNA
$488M
| $9.97M | ﹤0.01% |
104,741
-116,038
| -53% | -$14.2M |
|
1312
Lincoln National
LNC
$8.67B
| $9.85M | ﹤0.01% |
210,544
-23,653
| -10% | -$1.35M |
|
1313
Universal Health Services
UHS
$10.1B
| $9.79M | ﹤0.01% |
97,230
-9,608
| -9% | -$1.2M |
|
1314
Oxford Industries
OXM
$542M
| $9.73M | ﹤0.01% |
109,696
-6,961
| -6% | -$625K |
|
1315
Arcutis Biotherapeutics
ARQT
$3.25B
| $9.65M | ﹤0.01% |
453,057
+4,355
| +1% | +$89.3K |
|
1316
Hayward Holdings
HAYW
$3.24B
| $9.65M | ﹤0.01% |
670,546
+132,920
| +25% | +$2.05M |
|
1317
Markel Group
MKL
$22.8B
| $9.6M | ﹤0.01% |
7,421
-17
| -0.2% | -$23.3K |
|
|
EXAI
1318
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $9.48M | ﹤0.01% |
870,644
-25,332
| -3% | -$302K |
|
|
SIX
1319
DELISTED
Six Flags Entertainment Corp.
SIX
| $9.4M | ﹤0.01% |
433,346
-81,873
| -16% | -$2.61M |
|
1320
Carriage Services
CSV
$555M
| $9.39M | ﹤0.01% |
236,839
+228,855
| +2,866% | +$9.88M |
|
1321
Artesian Resources
ARTNA
$369M
| $9.37M | ﹤0.01% |
190,623
+66,776
| +54% | +$3.14M |
|
1322
Ranpak Holdings
PACK
$479M
| $9.32M | ﹤0.01% |
1,330,832
-26,755
| -2% | -$345K |
|
1323
DXC Technology
DXC
$1.79B
| $9.31M | ﹤0.01% |
307,164
-34,832
| -10% | -$1.08M |
|
1324
Sprott Physical Gold and Silver Trust
CEF
$8.17B
| $9.29M | ﹤0.01% |
552,560
-26,200
| -5% | -$475K |
|
1325
Newell Brands
NWL
$2.63B
| $9.28M | ﹤0.01% |
487,210
-49,079
| -9% | -$1.04M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.